Replies to post #237922 on Biotech Values

[dewophile]

I think they said there was some stocking. Regardless of the market share everyone is being hit right now. I listened to 2 ccs last 2 days both mentioned it. Gsk said ovarian debulking down 20 percent (good sales of PARP despite this). SGEN HL diagnoses down accounting for dip in adcetris So have to think a scenario like this with asymptomatic patients covid effects are going to be even more pronounced